Adderall (generic medication: amphetamine salts) is used to treat ADHD symptoms
A new analysis of data from the SELECT trial shows that semaglutide, a GLP-1 receptor agonist, provides a clear cardiovascular protective effect in people with overweight or obesity and already established cardiovascular disease, even when they do not have diabetes
For there to be cost-effectiveness in saving money on claims related to cardiovascular disease, these drugs for weight loss should be priced at $7,500 to $9,800 annually
J Biol Chem (2010) 285:19892002
Blood glucose studies following GHRP-6 administration have not shown hypoglycemic readings
Each of these methods can lead to weight loss and improved metabolic health, provided they reduce overall calorie intake